Craft

G&E Herbal

Stock Price

NT$58.3

2024-10-29

Market Capitalization

NT$3.4 B

2024-10-29

Revenue

NT$309.1 M

FY, 2025

G&E Herbal Summary

Company Summary

Overview
G&E Herbal (德英生物科技股份有限司) biopharmaceutical company that manufactures and distributes health care products. It offers dietary supplements, conventional drugs, cosmetics, capsules, and other products.
Type
Public
Status
Active
Founded
2002
Website
https://www.geherbs.com
Sectors

Table of Contents

G&E Herbal Financials

Summary Financials

Revenue (Q1, 2026)
NT$32.2M
Gross profit (Q1, 2026)
NT$25.3M
Net income (Q1, 2026)
NT$14.9M
Cash (Q1, 2026)
NT$59.8M
EBIT (Q1, 2026)
NT$5.4M
Enterprise value
$3.4B

Footer menu